sodium bicarbonate · Baxter Hlthcare Corp · NDA 218524, 220790
Sodium Bicarbonate
Earliest generic entry, as listed · earliest of 2 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220788, Aspiro · 218524-001Approved 15 Apr 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 217523, Amneal · 218524-001Approved 13 Jan 2026Detected 25 Oct 2026Historical import
- Generic approved · ANDA 219089, Milla Pharms · 218524-001Approved 6 Jul 2026Detected 25 Oct 2026Historical import
Products covered · 2
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 218524 · 001 · RLD | solution, intravenous | 150MEQ/1000ML (0.15MEQ/ML) | open |
| 220790 · 001 · RLD | solution, intravenous | 150MEQ/1000ML (0.15MEQ/ML) | open |